Your browser doesn't support javascript.
loading
Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population.
Rehman, Saima F; Mansoor, Qaisar; Farooqi, Ammad A; Nazir, Nusrat; Kausar, Rukhsana; Jabeen, Nyla; Ismail, Muhammad.
Afiliación
  • Rehman SF; Department of Bioinformatics and Biotechnology, International Islamic University (IIU), Islamabad; Institute of Biomedical and Genetic Engineering (IBGE), G-9/1, Islamabad, Pakistan.
  • Mansoor Q; Institute of Biomedical and Genetic Engineering (IBGE), G-9/1, Islamabad, Pakistan.
  • Farooqi AA; Institute of Biomedical and Genetic Engineering (IBGE), G-9/1, Islamabad, Pakistan.
  • Nazir N; Department of Pharmacology, Army Medical College, Rawalpindi, Pakistan.
  • Kausar R; Department of Bioinformatics and Biotechnology, International Islamic University (IIU), Islamabad.
  • Jabeen N; Department of Bioinformatics and Biotechnology, International Islamic University (IIU), Islamabad.
  • Ismail M; Institute of Biomedical and Genetic Engineering (IBGE), G-9/1, Islamabad, Pakistan.
Contemp Oncol (Pozn) ; 20(2): 185-7, 2016.
Article en En | MEDLINE | ID: mdl-27358600
ABSTRACT
AIM OF THE STUDY TRAIL-mediated signalling has emerged as an extensively studied biological mechanism reported to differentially induce apoptosis in cancer cells. However, overwhelmingly increasing experimentally verified data is shedding light on resistance against TRAIL-induced apoptosis in cancer cells. Moreover, genetic and epigenetic mutations also exert effects on the functionality of TRAIL and its receptors. In this study we investigated the association between breast cancer and polymorphisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in a Pakistani Population. MATERIAL AND

METHODS:

Genotyping for TRAIL gene 1595 C/T polymorphism was done for 363 breast cancer patients and 193 age- and sex-matched healthy controls. DNA was extracted using standard organic methods. PCR-RFLP analysis was done for C/T polymorphism at position 1595 in exon 5 of the TRAIL gene using site-specific primers and restriction enzyme. The results were statistically evaluated by SPSS14.

RESULTS:

In this study, CC homozygotes were 46.3% in patients and 49.7% in controls, p = 0.729 with OR value 0.8705 (95% CI 0.6137-1.2348). CT was statistically insignificant, p = 0.837 with OR value 0.9242 (95% CI 0.6494-1.3154). However, the minor allele or risk allele genotype TT had a higher percentage among breast cancer patients (12.1%) than in the control group (6.7%). Since there was a statistically insignificant difference (p = 0.212, OR value 1.9098 with 95% CI 1.0019 to 3.6406) of TT genotype between the two groups, the contrastingly higher percentage of TT genotype in breast cancer patients seems to be a risk factor for the disease. Moreover, the frequency of minor allele T was also found to be higher in the patients (0.329) than in the controls (0.285).

CONCLUSIONS:

The TRAIL gene 1595 C/T SNP has a contradictory role in cancer development in different populations. In our population group although the percentage of homozygous risk allele TT was higher in patients it was statistically non-significant. The raised T allele and TT genotype in patients may suggest its association with breast cancer in the Pakistani population.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Contemp Oncol (Pozn) Año: 2016 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Contemp Oncol (Pozn) Año: 2016 Tipo del documento: Article País de afiliación: Pakistán